about
Interventions for infected cysts in people with autosomal dominant polycystic kidney diseaseAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance PredictionPharmacodynamics of antimicrobials against Mycoplasma mycoides mycoides small colony, the causative agent of contagious bovine pleuropneumoniaAntibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermediusDelineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expressionRelevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage AdjustmentsDetermination of the antibacterial activity of simvastatin against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: An in vitro study.General principles of antimicrobial therapy.In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TBIntegration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.Azithromycin enhances phagocytic killing of Aggregatibacter actinomycetemcomitans Y4 by human neutrophils.Pharmacodynamic modelling of in vitro activity of tetracycline against a representative, naturally occurring population of porcine Escherichia coli.Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.Shaping Nanoparticles with Hydrophilic Compositions and Hydrophobic Properties as Nanocarriers for Antibiotic Delivery.In Vitro Antibacterial Activity of Essential Oils against Streptococcus pyogenes.High azithromycin concentration in lungs by way of bovine serum albumin microspheres as targeted drug delivery: lung targeting efficiency in albino mice.Pharmacotherapy of diabetic foot osteomyelitis.Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Evaluation of the anti-candidal activity of methanolic leaf extract of cleistopholis patens (fam. Annonaceae) on candida species isolated from stage II HIV patients.Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.Pharmacotherapy for community-acquired pneumonia in the elderly.Bacteriostatic Effect of Simvastatin on Selected Oral Streptococci in Vitro.Pharmacological indices and pulmonary distribution of rifampicin after repeated oral administration in healthy foals.Beyond conventional antibiotics - New directions for combination products to combat biofilm.Non-halogenated new sesquiterpenes from Bornean Laurencia snackeyi.A new cembrane-type diterpenoid from Bornean liverwort Chandonanthus hirtellus.Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses.Bactericidal Effect of Pterostilbene Alone and in Combination with Gentamicin against Human Pathogenic Bacteria.Lack of antimicrobial bactericidal activity in Mycobacterium abscessus.Chemical composition and antibacterial and cytotoxic activities of Allium hirtifolium BoissAminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria.In vitro inhibitory and cytotoxic activity of MFM 501, a novel codonopsinine derivative, against Methicillin-Resistant Staphylococcus aureus clinical isolates.Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.Studying the activity of antitubercluosis drugs inside electrospun polyvinyl alcohol, polyethylene oxide, and polycaprolacton nanofibers.In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals.Predicting the dynamics of bacterial growth inhibition by ribosome-targeting antibiotics.New anti-bacterial halogenated tricyclic sesquiterpenes from Bornean Laurencia majuscula (Harvey) Lucas.Antimicrobial lectin from Schinus terebinthifolius leaf.
P2860
Q24201315-E9276E7C-6098-4012-8964-BE6CE02FC90BQ26739860-A11CF2D0-CCE1-4CAC-A8C9-FFAE958B2F89Q26753831-EDCB7AA3-90E4-4B1D-B2BD-482F0BCFBE92Q28482671-DB8EA511-0246-44AF-ABCA-C7548DB75ECCQ28548455-F349406A-B04F-4564-9982-1EA0A45D2B33Q33467406-A5BA969A-AE1D-43CD-A0BD-5A8512996094Q33763177-61AB361C-F63C-4EBA-9EB4-A04B406DB72DQ34102813-67B9A77C-4148-410A-9380-D734B434B537Q34161745-85A1083C-DFF6-40B2-B8B6-FCB7227468C7Q34591451-2A1F71AE-A4D9-49C8-86A0-86FB26F093F5Q35750265-E308645E-AA03-4881-AC74-6BB6174E2B13Q35977242-4322AAB8-D0ED-46C9-B247-86CB5292D3EDQ36310839-122D780B-0020-4CD3-900B-2EB0B5CE22CAQ36437749-2BD644B2-1894-4894-A5A2-63114CB14BF9Q36786720-F8448ED9-3877-4A82-917D-D54BE8C0528DQ36801852-5BDC8ED9-07D3-4C9C-8F43-862A616B9268Q36875820-6D1CDDD5-C0C6-4A6C-9A47-B46E40D246A7Q37642761-C3744AC5-77C4-43C3-883E-7DF6C12E375FQ38100704-425E7C1E-E6FC-425C-90F4-B8ACA4F78421Q38117578-C283414D-E9B9-455B-AC19-C4A7C131ADFEQ38613098-FC865ADE-22AB-4334-B2BE-D7C4855A3BFDQ38664871-F7A2BDBF-B0F6-41AE-B478-ACC1AA9649ADQ38731918-3DCD7BCE-A62B-4BDA-A244-70908B39A72BQ38752447-375A0DC7-D47A-4E16-8C92-5C19F9BB685CQ38773623-772B4D70-E30B-4223-A54B-CEB58EAC1732Q38920223-3061B1E3-72E5-4007-96D8-9BC0B0E1C70DQ39117090-45BA8C35-4143-4429-9BF0-795F7DB653F9Q39301327-36578088-F099-46DF-83A0-1ABF62D15E83Q39376296-2C338629-F6C9-44A5-ADF7-C3243ECBE099Q40290158-2B29AB0F-183E-435D-ACC5-C6D16E351495Q41079534-69D39B19-A756-4046-9092-98556EB86021Q41478499-34CF92DA-4C80-4277-882A-E84FD2292FF3Q41532035-3A7B11E2-0907-4C1D-9204-1FD5F740FF36Q41776468-24F2E790-6E5D-4E79-913B-BFB884C7675FQ44481718-E71E0C58-97AE-431E-8043-1191A3E4BF56Q44992201-4AF777C6-1EDD-483D-BB73-9E110DE332CCQ45564582-02584D22-E01D-4BB8-A96F-E190B3D689CFQ47111173-7952B135-E705-41E5-887D-E0C4E5072650Q47675272-88D4F862-F1CB-47CD-A04C-BF127E386DB7Q50020900-B8216E22-5A35-4141-932D-E953D90E6C70
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacodynamics of antimicrobial drugs.
@ast
Pharmacodynamics of antimicrobial drugs.
@en
type
label
Pharmacodynamics of antimicrobial drugs.
@ast
Pharmacodynamics of antimicrobial drugs.
@en
prefLabel
Pharmacodynamics of antimicrobial drugs.
@ast
Pharmacodynamics of antimicrobial drugs.
@en
P1476
Pharmacodynamics of antimicrobial drugs.
@en
P2093
Matthew E Levison
P304
451-65, vii
P356
10.1016/J.IDC.2004.04.012
P577
2004-09-01T00:00:00Z